Page last updated: 2024-09-05

sb 203580 and Endometrial Neoplasms

sb 203580 has been researched along with Endometrial Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, XM; Shen, HM; Wang, XY; Xiao, L; Xu, CF; Yang, YB1
Li, T; Li, XM; Wang, XY; Xiao, L; Xu, CF; Yang, YB1
Bai, W; Jiang, F; Lee, H; Nicosia, SV; Su, B; Wang, Q; Yang, J1

Other Studies

3 other study(ies) available for sb 203580 and Endometrial Neoplasms

ArticleYear
[Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression].
    Zhonghua fu chan ke za zhi, 2009, Volume: 44, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endometrial Neoplasms; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Imidazoles; PTEN Phosphohydrolase; Pyridines; Signal Transduction; Sirolimus; Transfection; Tyrphostins

2009
Differential sensitivity of human endometrial carcinoma cells with different PTEN expression to mitogen-activated protein kinase signaling inhibits and implications for therapy.
    Journal of cancer research and clinical oncology, 2010, Volume: 136, Issue:7

    Topics: Activating Transcription Factor 2; Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Endometrial Neoplasms; Female; Humans; Imidazoles; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridines; Sensitivity and Specificity; Tumor Cells, Cultured

2010
MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells.
    Molecular endocrinology (Baltimore, Md.), 2000, Volume: 14, Issue:11

    Topics: Endometrial Neoplasms; Enzyme Activation; Enzyme Inhibitors; Estrogen Antagonists; Estrogen Receptor alpha; Female; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinase 2; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-raf; Pyridines; Receptors, Estrogen; Tamoxifen; Transcription, Genetic; Tumor Cells, Cultured

2000